Based on molecular markers, including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), breast cancer can be divided into three subtypes: hormone receptor (HR) positive, HER2 positive and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.